| Dr Geraldene E Moore, PH D | |
|
3805 Mccain Park Drive, Suite 116, North Little Rock, AR 72116-7813 | |
| (501) 758-9993 | |
| (501) 758-5321 |
| Full Name | Dr Geraldene E Moore |
|---|---|
| Gender | Female |
| Speciality | Psychologist |
| Location | 3805 Mccain Park Drive, North Little Rock, Arkansas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063428365 | NPI | - | NPPES |
| 56579 | Other | AR | BCBS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103T00000X | Psychologist | 869P (Arkansas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Geraldene E Moore, PH D 3805 Mccain Park Drive, Suite 116, North Little Rock, AR 72116-7813 Ph: (501) 758-9993 | Dr Geraldene E Moore, PH D 3805 Mccain Park Drive, Suite 116, North Little Rock, AR 72116-7813 Ph: (501) 758-9993 |
News Archive
Pfizer Inc. announced today that the U.S. Food and Drug Administration (FDA) has not yet completed its review of the Biologics License Application (BLA) for Prevnar 13™, (Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein]), the Company's candidate 13-valent pneumococcal conjugate vaccine.
Combining single-cell genomics and computational techniques, a research team including Paul Robson, Ph.D., director of single-cell biology at The Jackson Laboratory, has defined cell-type composition of cancerous cells from 11 colorectal tumors, as well as adjacent noncancerous cells, a key to more targeted diagnosis and treatment.
Clinical trial results from Array BioPharma's wholly-owned MEK inhibitor, binimetinib, and BRAF inhibitor, encorafenib, were presented this weekend at the European Society of Medical Oncology's annual European Cancer Conference (ECC). At the meeting, preliminary data were shared from both a Phase 2 combination trial of binimetinib and encorafenib in BRAF-mutant melanoma patients (LOGIC2) and a Phase 1b/2 combination trial of binimetinib and ribociclib (Novartis, LEE011), a CDK4/6 inhibitor in NRAS-mutant melanoma patients.
Eclipsys Corporation®, The Outcomes Company®, today announced that Singapore General Hospital (SGH), Singapore's oldest and largest acute tertiary hospital and national referral center, has successfully activated Eclipsys' Sunrise Patient Flow™ solution.
Many elderly people in residential care feel insecure during relocation or renovation work - but there are ways of handling the situation. Those who manage to create a sense of home where they live are in a better position to cope with the stresses that go with change, reveals a thesis from the Sahlgrenska Academy.
› Verified 3 days ago
Dr. Arielle Rebekah Askren Marston, PSYD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 5401 Jfk Blvd Ste G, North Little Rock, AR 72116 Phone: 501-492-9902 | |
Mr. Lewis E. Campbell, LPE-I Psychologist Medicare: Not Enrolled in Medicare Practice Location: 4705 Somers Ave, Suite 1027, North Little Rock, AR 72116 Phone: 501-771-9910 Fax: 501-758-7116 | |
Dr. John M Ray, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 2200 Fort Roots Dr 116b/nlr, North Little Rock, AR 72114 Phone: 501-257-2321 | |
Dr. John Alvin Lierly Jr., PH.D. Psychologist Medicare: Medicare Enrolled Practice Location: 4020 Richards Rd, Suite F, North Little Rock, AR 72117 Phone: 501-753-1616 Fax: 501-753-8471 | |
Dr. Kevin R Reeder, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 2200 Fort Roots Dr, North Little Rock, AR 72114 Phone: 615-542-3080 | |
Dr. Katherine Green Pope, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1301 Main St, North Little Rock, AR 72114 Phone: 501-658-4900 |